Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

53.78
Delayed Data
As of 4:03pm ET
 +0.77 / +1.45%
Today’s Change
46.17
Today|||52-Week Range
60.34
-7.40%
Year-to-Date
Eli Lilly Stock Up on FDA Advisory Panel Vote for Jardiance
10:29am / Zacks.com - Paid Partner Content
What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?
Jun 20 / MotleyFool.com - Paid Partner Content
Is $2.8 Billion Just The Beginning For This Novo Nordisk Diabetes Drug
9:24am / MotleyFool.com - Paid Partner Content
5 Companies We'd Buy and Hold for the Next 20 Years
Jun 20 / MotleyFool.com - Paid Partner Content
High Yield, Strong Returns: Sturm Ruger, Nu Skin Enterprises
Jun 23 / GuruFocus News - Paid Partner Content
Diabetes Deep-Dive: What Investors Need to Know About This Devastating Disease
Jun 18 / MotleyFool.com - Paid Partner Content
How Big Is the Diabetes Treatment Market?
Jun 22 / MotleyFool.com - Paid Partner Content
Getting OLD but want to be SLIM? There are ETFs for that
Jun 09 / CNNMoney.com